Clinical Trial: Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related Biomarker

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

---

Official Title: A Randomized, Control,Open Label, Multicentre Clinical Study to Evaluate the Efficacy and Safety of Cilostazol and Probucol Alone and in Combination on Atherosclerosis Related Biomarker

Brief Summary:

1. To evaluate the efficacy of Cilostazol and Probucol alone and in combination on atherosclerosis related biomarker
2. To evaluate the safety of Cilostazol and Probucol alone and in combination on atherosclerosis related biomarker